Life Sciences

FDA Quality Management Maturity Program

January 15, 2024 || Martina McDonagh
 
Drug shortages in the pharmaceutical industry is a significant concern that has far-reaching consequences for the industry, the regulators, the healthcare system, and ultimately the patients. These shortages can be for a variety of factors including manufacturing and quality issues. To this end the FDA embarked on the Quality Management…

CAI: Evolving Past Commissioning  

December 7, 2023 || David Shenberger
 
In the dynamic world of life sciences, companies that embrace change and adapt to changing market needs are the ones that thrive. Our journey began in 1996 with a singular purpose: to change how the life sciences industry delivers facilities through robust commissioning. As we have grown and gained valuable…